Eli Lilly extends tender offer to acquire POINT Biopharma to 15 Dec Ruchika Sharma5 Dec 2023 2:45 PM ISTIndianapolis: Eli Lilly and Company has announced the extension of the expiration of the tender offer to acquire all of the issued and...
Eli Lilly secures USFDA nod for leukemia treatment Jaypirca Ruchika Sharma2 Dec 2023 1:30 PM ISTThis is the second FDA-approved indication for Jaypirca following the January 2023 Accelerated Approval for the treatment of adult patients with...
Teva Pharma drops migraine drug patent case against Eli Lilly Ruchika Sharma29 Nov 2023 1:30 PM ISTUnited States: Israel-based drugmaker Teva Pharmaceuticals has agreed to end a patent lawsuit over Eli Lilly's migraine drug Emgality...
Eli Lilly bags USFDA nod for Zepbound injection for weight loss Ruchika Sharma9 Nov 2023 1:30 PM ISTZepbound should be used with a reduced-calorie diet and increased physical activity.
Novo Nordisk, Eli Lilly see insatiable demand for weight loss drugs Ruchika Sharma5 Nov 2023 10:00 AM ISTNovo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by...
Eli Lilly gets CDSCO Panel Nod To study antidiabetic drug Orforglipron Dr. Divya Colin28 Oct 2023 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Eli Lilly Omvoh gets USFDA okay for Ulcerative Colitis in adults Ruchika Sharma27 Oct 2023 12:19 PM ISTOmvoh will be available in the United States in the coming weeks.
Eli Lilly to acquire Mablink Bioscience Ruchika Sharma22 Oct 2023 3:15 PM ISTFrance: Mablink Bioscience, a pre-clinical biotechnology has announced an agreement to be acquired by Eli Lilly and Company.PSARlink, an innovative...
Eli Lilly Mirikizumab helps patients with Crohn's Disease achieve long-term Remission in Phase 3 trial Ruchika Sharma15 Oct 2023 12:30 PM ISTIndianapolis: Eli Lilly and Company has announced that mirikizumab (an investigational interleukin-23p19 antagonist) has met the co-primary...
CDSCO Panel Grants Eli Lilly's Protocol Amendment Proposal of Baricitinib Study Dr. Divya Colin8 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Eli Lilly to acquire POINT Biopharma for USD 1.4 billion Ruchika Sharma7 Oct 2023 3:46 PM ISTIndianapolis: Eli Lilly and Company and POINT Biopharma Global, Inc. have announced a definitive agreement for Lilly to acquire POINT, a...
Eli Lilly eczema drug lebrikizumab rejected by USFDA Ruchika Sharma4 Oct 2023 2:30 PM ISTIndianapolis: The U.S. Food and Drug Administration (FDA) has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain...
